USGI Medical Completes Enrollment in U.S. Pivotal Study of Incisionless Weight Loss Procedure

SAN CLEMENTE, Calif., July 9, 2014 /PRNewswire/ — USGI Medical, Inc., a company pioneering research in the area of incisionless, endoscopic procedures for weight loss, reflux and advanced therapeutic endoscopy, announced that on June 9, 2014, enrollment was completed for the ESSENTIAL Trial™, a U.S.-based pivotal study designed to prospectively compare weight loss results between an endoscopic procedure and a sham procedure.  The endoscopic procedure is known as POSE™ (Primary Obesity Surgery, Endolumenal).  The ESSENTIAL Trial is one of the largest multicenter, randomized, sham-controlled studies of an endoscopic procedure for weight loss ever conducted

Learn More